KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Guardant Health (GH) Accumulated Depreciation & Amortization (2017 - 2025)

Guardant Health's Accumulated Depreciation & Amortization history spans 9 years, with the latest figure at $39.7 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 6.25% year-over-year to $39.7 million; the TTM value through Dec 2025 reached $39.7 million, down 6.25%, while the annual FY2025 figure was $39.7 million, 6.25% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $39.7 million at Guardant Health, up from $29.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $42.9 million in Q4 2023 and bottomed at $5.0 million in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $21.2 million (2023), against an average of $22.6 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization skyrocketed 61.47% in 2022 before it decreased 7.04% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $22.3 million in 2021, then surged by 61.47% to $36.0 million in 2022, then increased by 19.24% to $42.9 million in 2023, then fell by 1.15% to $42.4 million in 2024, then fell by 6.25% to $39.7 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Accumulated Depreciation & Amortization are $39.7 million (Q4 2025), $29.7 million (Q3 2025), and $20.3 million (Q2 2025).